Objective: Preterm and term pre-eclampsia may differ in etiology. This could be reflected in differences in placenta weight. Therefore, we compared placenta weight in pregnancies with preterm or term pre-eclampsia to placenta weight in pregnancies without pre-eclampsia.
Design: Population study.
Setting: Medical Birth Registry of Norway.
Population: All singleton pregnancies in Norway from 1999 through 2004 delivered at or after 21 weeks' gestation (n=317,688).
Methods: Placenta weight in pregnancies without pre-eclampsia (n=304,875) was compared to placenta weight in pregnancies with preterm pre-eclampsia (delivery before week 37 of pregnancy, n=3,070) and term pre-eclampsia (delivery on or after week 37 of pregnancy, n=9,743). Placenta weight z-scores were calculated to adjust for offspring sex and length of gestation, and grouped in tenths. Placenta weight according to pre-eclampsia status is presented as proportions within each tenth.
Main Outcome Measures: Pre-eclampsia status.
Results: In preterm pre-eclampsia, placentas were over-represented in the two lowest (33.8%; 95% CI 32.1-35.5) and under-represented in the two highest (13.1%; 95% CI 11.9-14.3) tenths of placenta weight compared to pregnancies without pre-eclampsia (20%). In term pre-eclampsia, placentas were over-represented in the two lowest (22.0%; 95% CI 21.2-22.8) and the two highest (22.7%; 95% CI 21.9-23.6) placenta weight groups. Mean placenta weight z-score was higher in term pre-eclampsia compared to pregnancies without pre-eclampsia.
Conclusions: Small placentas were associated with pre-eclampsia, and more strongly with preterm than term pre-eclampsia. In term pre-eclampsia, the association with placenta weight was u-shaped, yielding higher proportions of both low and high placenta weight compared to pregnancies without pre-eclampsia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00016340802056178 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Maternal exposure to fullerenols impairs placental development in mice by inhibiting estriol synthesis and reducing ERα.
J Nanobiotechnology
January 2025
Key Laboratory of Human Genetics and Environmental Medicine, Xuzhou Medical University, Xuzhou, 221004, China.
Fullerenols, a water-soluble polyhydroxy derivative of fullerene, hold promise in medical and materials science due to their unique properties. However, concerns about their potential embryotoxicity remain. Using a pregnancy mouse model and metabolomics analysis, our findings reveal that fullerenols exposure during pregnancy not only significantly reduced mice placental weight and villi thickness, but also altered the classes and concentrations of metabolites in the mouse placenta.
View Article and Find Full Text PDFManagement of haemolysis-induced hyperkalaemia in an extremely low birthweight infant exposed to maternal sulfasalazine.
BMJ Case Rep
January 2025
Neonatology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Sulfasalazine is a non-specific immunomodulator with haemolytic anaemia as a known side effect that crosses the placenta. We present a preterm neonate with cardiac arrhythmia secondary to hyperkalaemia in the setting of maternal sulfasalazine therapy. A preterm infant was born to a mother taking hydroxychloroquine, sulfasalazine, aspirin and enoxaparin throughout pregnancy.
View Article and Find Full Text PDFPlacental Membrane Transplantation: Can It Be A Solution For Tissue Defect Repair In Giant Omphaloceles.
Transplant Proc
January 2025
Department of Perinatology, Istanbul Zeynep Kamil Maternity and Children's Diseases Health Training and Research Center, University of Health Sciences, Istanbul, Turkey. Electronic address:
Objectives: This study aimed to evaluate the effect of placental membrane covering of the omphalocele sac on the healing of giant omphaloceles requiring silo repair that could not be treated primarily.
Methods: This prospective study was performed between October 2021 and October 2023 with the approval of our hospital's ethics committee. All pregnant women diagnosed with prenatal giant omphalocele were informed that their own placenta could be used for omphalocele repair if necessary, and their consent was obtained.
Sodium tanshinone IIA sulfonate alleviates fetal growth restriction by mediating aquaporin-3 expression in placental trophoblast cells.
FASEB J
January 2025
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Fetal growth restriction (FGR) is characterized by the inability of the fetus to achieve its growth potential due to pathological factors, most commonly impaired placental trophoblast cell function. Currently, effective prevention and treatment methods of FGR are limited. We aimed to explore the pathogenesis of FGR and provide potential strategies for mitigating its occurrence.
View Article and Find Full Text PDFThe Effect of Boric Acid on Oxidative Stress, Inflammation, and Apoptosis in Embryonic and Fetal Tissues Damage Caused by Consumption of High-Fructose Corn Syrup in Pregnant Rats.
Reprod Sci
January 2025
Department of Medical Services and Techniques, Pathology Program, Vocational School of Health Services, Gümüşhane University, Gümüşhane, Turkey.
This study aimed to determine the protective role of boric acid in a pregnant rat model of high fructose corn syrup consumption. Consumption of high fructose corn syrup has been associated with adverse health outcomes in humans and animals. Twenty-eight healthy female Wistar albino rats (250-300 g weight and 16-24 weeks old) were randomly distributed into four equal groups (n = 7): Control, Boric acid (BA), High Fructose Corn Syrup (HFCS), HFCS + BA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!